Galle PR - Search Results

1

CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.

Staib F, Krupp M, Maass T, Itzel T, Weinmann A, Lee JS, Schmidt B, Müller M, Thorgeirsson SS, Galle PR, Teufel A. Staib F, et al. Among authors: galle pr. Liver Int. 2014 Apr;34(4):621-31. doi: 10.1111/liv.12292. Epub 2013 Sep 9. Liver Int. 2014. PMID: 24016071 Free PMC article.

2

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.

Volkmann M, Müller M, Hofmann WJ, Meyer M, Hagelstein J, Räth U, Kommerell B, Zentgraf H, Galle PR. Volkmann M, et al. Among authors: galle pr. Hepatology. 1993 Sep;18(3):559-65. Hepatology. 1993. PMID: 7689531

3

p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.

Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Zentgraf H, Galle PR. Volkmann M, et al. Among authors: galle pr. Oncogene. 1994 Jan;9(1):195-204. Oncogene. 1994. PMID: 8302580

4

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR. Strand S, et al. Among authors: galle pr. Nat Med. 1996 Dec;2(12):1361-6. doi: 10.1038/nm1296-1361. Nat Med. 1996. PMID: 8946836

5

Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.

Heike M, Weinmann A, Bethke K, Galle PR. Heike M, et al. Among authors: galle pr. Biochem Pharmacol. 1999 Nov 1;58(9):1381-7. doi: 10.1016/s0006-2952(99)00178-1. Biochem Pharmacol. 1999. PMID: 10513981

6

Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60.

Bethke K, Staib F, Distler M, Schmitt U, Jonuleit H, Enk AH, Galle PR, Heike M. Bethke K, et al. Among authors: galle pr. J Immunol. 2002 Dec 1;169(11):6141-8. doi: 10.4049/jimmunol.169.11.6141. J Immunol. 2002. PMID: 12444117

7

Cross-presentation of human melanoma peptide antigen MART-1 to CTLs from in vitro reconstituted gp96/MART-1 complexes.

Staib F, Distler M, Bethke K, Schmitt U, Galle PR, Heike M. Staib F, et al. Among authors: galle pr. Cancer Immun. 2004 Apr 16;4:3. Cancer Immun. 2004. PMID: 15086273

8

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.

Teufel A, Steinmann S, Siebler J, Zanke C, Hohl H, Adami B, Schroeder M, Klein O, Höhler T, Galle PR, Heike M, Moehler M. Teufel A, et al. Among authors: galle pr. BMC Cancer. 2004 Jul 20;4:38. doi: 10.1186/1471-2407-4-38. BMC Cancer. 2004. PMID: 15265233 Free PMC article. Clinical Trial.

9

Characterization of OEBT, a LIM protein.

Teufel A, Weinmann A, Galle PR, Lohse AW. Teufel A, et al. Among authors: galle pr. Int J Mol Med. 2005 Mar;15(3):513-8. Int J Mol Med. 2005. PMID: 15702247

10

New chemotherapeutic strategies in colorectal cancer.

Moehler M, Teufel A, Galle PR. Moehler M, et al. Among authors: galle pr. Recent Results Cancer Res. 2005;165:250-9. doi: 10.1007/3-540-27449-9_28. Recent Results Cancer Res. 2005. PMID: 15865041 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters